Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study

Renal impairment (RI) is a negative prognostic factor in Multiple Myeloma (MM) and affected patients are often excluded from autologous stem cell transplantation (ASCT). However, it remains unclear whether historically inferior outcome data still hold true. From a total of 475 eligible MM patients w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC cancer 2018-10, Vol.18 (1), p.1008-1008, Article 1008
Hauptverfasser: Antlanger, Marlies, Dust, Tobias, Reiter, Thomas, Böhm, Alexandra, Lamm, Wolfgang W, Gornicec, Max, Willenbacher, Ella, Nachbaur, David, Weger, Roman, Rabitsch, Werner, Rasoul-Rockenschaub, Susanne, Worel, Nina, Lechner, Daniel, Greinix, Hildegard, Keil, Felix, Gisslinger, Heinz, Agis, Hermine, Krauth, Maria-Theresa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Renal impairment (RI) is a negative prognostic factor in Multiple Myeloma (MM) and affected patients are often excluded from autologous stem cell transplantation (ASCT). However, it remains unclear whether historically inferior outcome data still hold true. From a total of 475 eligible MM patients who had undergone ASCT between 1998 and 2016, 374 were included in this multi-centric retrospective cohort study. Renal function was determined both at the time of MM diagnosis and ASCT by estimated glomerular filtration rate (eGFR according to the MDRD formula, RI defined as eGFR
ISSN:1471-2407
1471-2407
DOI:10.1186/s12885-018-4926-0